NervoAct contains Palmitoylethanolamide (PEA), is an endogenous fatty acid amide, naturally produced in the human body, and has a protective effect as it is distributed in many tissues of the body and especially in the nervous tissue, where through a variety of cellular functions it is involved in chronic pain and the inflammation.

PEA is synthesized by nerve cells, and systemic or local alteration of its tissue levels is associated with acute and chronic pain conditions.

Taking PEA to supplement the body's deficiency can be beneficial as clinical trials have shown that it protects neurons, has anti-inflammatory and analgesic properties in chronic or neuropathic pain, anticonvulsant properties, and reduces intraneural and perineural edema.

PHARMACOLOGY: metabolic pathways and molecular targets NervoAct

INDICATIONS:

Peripheral neuropathy
Neuralgia
Migraine
Neck pain
Chronic lower back pain
Lumbago
Sciatic, Pelvic Pain
Carpal tunnel
Postoperative pain
Rheumatoid arthritis
Diabetic neuropathic pain

PHARMACEUTICAL FORM:

Soft capsules.

PACKING:

Each package contains 30 capsules

DOSAGE:

2 capsules 600mg per day after a meal (1 capsule every 12 hours) for 40 days.

Then 1 capsule a day for 3 to 6 months.

WARNINGS:

Do not exceed the recommended daily dose.

Tel. Poison Center: 210 7793777

No. Gn. E.O.F.: 12950/08.02.2022